Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning-based model for prediction of carbamazepine- and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.

The World Allergy Organization journal·2026
Same author

Computational Design of Zinc Single-Atom Catalysts in Lantern Organic Framework.

Journal of computational chemistry·2026
Same author

Temperature-dependent ion migration underlies sequence-specific collapse of unstructured RNA.

Biophysical journal·2026
Same author

Partial Sigma Covalent Bonding in Transition Metals.

Journal of computational chemistry·2026
Same author

Poly(ADP-ribose) (PAR) exhibits ion-dependent structural properties distinct from RNA.

Nucleic acids research·2026
Same author

Small-Molecule Drug Discovery Targeting RNAs: Hope or Hype?

Journal of medicinal chemistry·2026

Related Experiment Video

Updated: Jun 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking.

Hung T Nguyen1, Ly Le, Thanh N Truong

  • 1Department of Chemistry, University of Utah.

Plos Currents
|March 2, 2012
PubMed
Summary
This summary is machine-generated.

Researchers identified promising antiviral drugs for H1N1pdm influenza by screening compounds against H5N1 neuraminidase. Six novel drug candidates demonstrated superior binding efficacy compared to Oseltamivir (Tamiflu).

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Related Experiment Videos

Last Updated: Jun 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Area of Science:

  • Virology
  • Drug Discovery
  • Computational Chemistry

Background:

  • The H1N1pdm influenza strain poses a significant public health threat.
  • Neuraminidase is a key target for antiviral drug development against influenza viruses.
  • Structural similarities between H1N1pdm and H5N1 neuraminidase allow for cross-species drug candidate screening.

Purpose of the Study:

  • To identify potent antiviral drug candidates for H1N1pdm influenza.
  • To evaluate the binding efficacy of existing and novel compounds against H1N1pdm neuraminidase.
  • To compare the drug ranking for H1N1pdm with previous findings for H5N1.

Main Methods:

  • Utilized a library of 27 NCI diversity set compounds known to bind H5N1 neuraminidase.
  • Performed molecular docking simulations against H1N1pdm neuraminidase using molecular dynamics ensembles.
  • Conducted detailed hydrogen bond network analysis for top-ranking drug candidates.

Main Results:

  • A revised ranking of antiviral drug candidates for H1N1pdm was established.
  • Oseltamivir (Tamiflu) and Peramivir were ranked higher than Zanamivir (Relenza) against H1N1pdm.
  • Six drug candidates exhibited superior binding affinity to H1N1pdm neuraminidase compared to Oseltamivir.

Conclusions:

  • The study proposes a list of 27 promising antiviral drugs for H1N1pdm.
  • Novel drug candidates show potential for more effective H1N1pdm treatment.
  • Computational screening provides a rapid method for identifying effective influenza antivirals.